|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | CP-690550, Tasocitinib | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C16H20N6O |
||||||
| 分子量 | 312.37 | CAS No. | 477600-75-2 | ||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 62 mg/mL (198.48 mM) | ||||
| Water | Insoluble | ||||||
| Ethanol | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM in cell-free assays, 20- to 100-fold less potent against JAK2 and JAK1. Tofacitinib inhibits the expression of antiapoptotic BCL-A1 and BCL-XL in human plasmacytoid dendritic cells (PDC) and induced PDC apoptosis. |
|---|---|
| in vitro | CP-690550 is a specific, orally inhibitor of JAK3, it is 20- to 100-fold less potent for JAK2 and JAK1 with IC50 of 20 nM and 112 nM, respectively. This compound doesn't have potent activity against 30 other kinases (all median IC50 > 3000 nM). It inhibits IL-2–induced proliferation with 30-fold greater potency than its effects on GM-CSF–induced proliferation. [1] This chemical effectively inhibits a murine mixed lymphocyte reaction (MLR) (IC50 = 91 nM). [2] It potently inhibits IL-4 induced upregulation of CD23 (IC50=57 nM) and class II major histocompatibility complex (MHCII) expression (IC50=71 nM) on murine B cells. [3] A recent research indicates low dose of this compound accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation. [4] |
| in vivo | In a murine model of heterotopic heart transplantation (DBA2 donor heart into C57/BL6 host), Tofacitinib results in a dose-dependent increase in survival of transplanted hearts.The EC50 (drug concentration in blood at which 50% of mice will maintain their graft for >28 days) to be ~60 ng/mL.This compound prevents rejection of allogeneic kidneys in nonhuman primate (NHPs, macaca fascicularis) (MST of 62 and 83 days for the 50 to 100 ng/ml groups and 200 to 400 ng/ml groups, respectively). [1] Mice chronically dosed with this compound (1.5-15 mg/kg/day) demonstrates dose and time-dependent alterations in lymphocyte subsets when examined by flow cytometry. The most dramatic change observed is a 96% reduction in splenic NK1.1+TCRb-cell numbers following 21 days of treatment. Delayed-type hypersensitivity (DTH) responses in sensitized mice are reduced in a dose-dependent manner following treatment with this chemical (1.87–30 mg/kg, s.c.). Extended survival of neonatal Balb/c hearts implanted into the ear pinna of MHC mismatched C3H/HEN mice is observed with this compound monotherapy (10–30 mg/kg/day), but improved upon combination with cyclosporin (10 mg/kg/day). [2] |
| キナーゼアッセイ | JAK3 Kinase Assay | |
|---|---|---|
| A fragment encoding the catalytic domain of human JAK3 (785aa to 1125aa, JH1 catalytic domain) is amplified by PCR from the full length cDNA and cloned into the EcoRI site of the baculovirus transfer vector pVL1393. Recombinant baculovirus is used to infect Sf9 (Spodoptera frugipedra) cells and recombinant GSTJAK3 fusion protein is isolated on glutathione sepharose. The fusion protein is eluted with reduced glutathione and stored in buffer containing 50 mM Tris, pH 7.5, 10 mM DTT and 10% glycerol. JAK3 kinase activity is measured by ELISA as follows: Plates are coated overnight with a random L-glutamic acid and tyrosine co-polymer (4:1) (100 ug/mL). The plates are washed and recombinant JAK3 JH1:GST (100 ng/well) with or without inhibitors is incubated at room temperature for 30 minutes, after which HRP-conjugated PY20 anti-phosphotyrosine antibody (ICN) is added and developed by TMB (3,3',5,5'-tetramethylbenzidine). Other kinases (Table 1) are produced in E. coli or in insect cells, depending upon what is found to be optimal for the given kinase. The catalytic activity of tyrosine kinases is easured using the aftorementioned ELISA, whereas serine/threonine kinases are assayed using radioactive enzyme assays. | ||
| 細胞アッセイ | 細胞株 | Human T blasts cell |
| 濃度 | 0-4000 nM | |
| 反応時間 | 4 days | |
| 実験の流れ | To measure IL-2-dependent proliferation, isolated lymphocytes are resuspended to a cell density of 1-2 × 106/mL in complete RPMI medium (RPMI 1640 containing 10% (w/v) fetal calf serum (FCS), 1%(w/v) penicillin and treptomycin).Phytohemagluttinin (PHA) is added to a final concentration of 10mg/mL, and the culture incubated for 3 days at 37 °C in a humidified 5% (v/v) CO2 incubator to upregulate IL-2R and JAK3 expression. IL-2 (200U/mL), with or without this compound is then added and the cells are incubated for 72 hours at 37 °C in a humidified 5% (v/v) CO2 incubator, after which 50 mL of 3H-thymidine (5mCi/mL) is added. The plates are incubated for an additional 18 hours, harvested with a 96-well harvester, and counted on a scintillation counter. HUO3 cells are maintained in culture with granulocyte-macrophage colony stimulating factor and human foreskin fibroblasts are maintained in culture with 10% fetal calf serum. This compound is added to freshly plated cells and cultured for 4 days. 3Hthymidine is added during the last 18 hours of the culture period. |
|
| 動物実験 | 動物モデル | DBA/2 and C57/BL6 mice |
| 投薬量 | 0-136 ng/mL | |
| 投与方法 | Administered via osmotic minipump infusion | |
|

Data from [Data independently produced by Arthritis Rheumatol , 2014, 66(1), 121-9]

Data from [Data independently produced by PLoS One, 2014, 9(11), e112014]

Data from [Data independently produced by Cancer Discov, 2012, 2(7), 591-7]
| A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities [ Cell Rep Med, 2025, S2666-3791(25)00102-8] | PubMed: 40147445 |
| In silico modeling guides identification of novel JAK1 variants associated with immune dysregulation [ EMBO Mol Med, 2025, 10.1038/s44321-025-00317-0] | PubMed: 41136770 |
| Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients [ J Crohns Colitis, 2025, 19(6)jjaf076] | PubMed: 40320713 |
| Keloids and inflammation: the crucial role of IL-33 in epidermal changes [ Front Immunol, 2025, 16:1514618] | PubMed: 40230853 |
| Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells [ Front Immunol, 2025, 16:1534462] | PubMed: 39981237 |
| Polarization of Vδ2 T cells to a Th2-like phenotype promotes plasmablast differentiation and possesses pro-fibrotic properties in IgG4-related disease [ Front Immunol, 2025, 16:1550405] | PubMed: 40213561 |
| Membrane-bound IL-15 co-expression powers a potent and persistent CD70-targeted TRuC T-cell therapy [ Front Immunol, 2025, 16:1609658] | PubMed: 40519930 |
| Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata [ Front Pharmacol, 2025, 16:1507348] | PubMed: 40438604 |
| Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy [ Rheumatology (Oxford), 2025, keaf227] | PubMed: 40372702 |
| Unidirectional Crosstalk Between NTRK1 and IGF2 Drives ER Stress in Chronic Pain [ Biomedicines, 2025, 13(7)1632] | PubMed: 40722704 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。